GV
Valicherla GR
Also known as: Raghavendra G
Pharmaron (Exton) Lab Services LLC, University of Pittsburgh, GVK Biosciences Pvt Ltd
Research areas: Pharmacology, Toxicology and Pharmaceutics · Pharmaceutical Science · Pharmacogenetics and Drug Metabolism · Analytical Methods in Pharmaceuticals · Drug Transport and Resistance Mechanisms
0000-0002-1180-2530
Employment
-
Pharmaron (Exton) Lab Services LLC Senior Scientist I2023 - Present
-
GVK Biosciences Pvt Ltd Scientific Manager2017 - 2019
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (39)
- Determining Critical Physiological and Drug Specific Parameters for Enhancing a Physiologically Based Pharmacokinetics Model for the Female Reproductive Tract Save
- Expanding the Gene Expression Profiling of Drug Transporters and Drug-Metabolizing Enzymes to Include the Upper Female Reproductive Tract Save
- In Vitro Pharmacokinetic Properties of MK-2048, a Potent Drug Candidate for HIV Prevention Save
- Mechanism‐Based Predictions of Local Tissue and Systemic Exposure for Drug Products Delivered Through the Female Reproductive Tract Save
- Simultaneous Estimation of Quercetin and trans-Resveratrol in Cissus quadrangularis Extract in Rat Serum Using Validated LC-MS/MS Method: Application to Pharmacokinetic and Stability Studies Save
- Transport and Permeation Properties of Dapivirine: Understanding Potential Drug-Drug Interactions Save
- Approaches to minimize the effects of P-glycoprotein in drug transport: A review. Save
- Evaluation of the Pharmacokinetics of the Pancreastatin Inhibitor PSTi8 Peptide in Rats: Integration of In Vitro and In Vivo Findings Save
- Investigating the Contribution of Drug-Metabolizing Enzymes in Drug-Drug Interactions of Dapivirine and Miconazole Save
- Drug delivery strategies for management of women's health issues in the upper genital tract. Save
- Expression, activity, and regulation of phosphorylating enzymes in tissues and cells relevant to HIV-1 sexual transmission. Save
- Elucidation of plasma protein binding, blood partitioning, permeability, CYP phenotyping and CYP inhibition studies of Withanone using validated UPLC method: An active constituent of neuroprotective herb Ashwagandha. Save
- Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice. Save
- LC-ESI-MS/MS assay development and validation of a novel antidiabetic peptide PSTi8 in mice plasma using SPE: An application to pharmacokinetics. Save
- Development and validation of LC-MS/MS method for quantification of novel PP2A - β-catenin signalling inhibitor, S011-2111 in mice plasma: Application to its preclinical pharmacokinetic studies. Save
- Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway. Save
- Pancreastatin inhibitor, PSTi8 ameliorates metabolic health by modulating AKT/GSK-3β and PKCλ/ζ/SREBP1c pathways in high fat diet induced insulin resistance in peri-/post-menopausal rats Save
- Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone induced fatty liver disease in C57BL/6 mice. Save
- Investigation of the Inhibition of Eight Major Human Cytochrome P450 Isozymes by a Probe Substrate Cocktail in vitro with Emphasis on CYP2E1. Save
- Elucidation of pharmacokinetics of novel DNA ligase I inhibitor, S012-1332 in rats: Integration of in vitro and in vivo findings Save